用深度大脑刺激治疗阿片类药物使用障碍的公众看法:评论分析研究研究
Patricia Henegan1, Jack Koczara2, Robyn Bluhm3,4
1Department of Engineering Science and Mechanics, Pennsylvania State University, University Park, PA, United States.
Online journal of public health informatics
|August 16, 2024
概括
关于阿片类药物使用障碍 (OUD) 深度大脑刺激 (DBS) 的公众观点显示,人们对治疗结果,成作为一种障碍和资源分配感到担忧. 了解这些看法是解决关于这种新型OUD治疗的错误信息的关键.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 生物伦理学生物伦理学
背景情况:
- 与阿片类药物相关的死亡人数急剧增加,需要针对阿片类药物使用障碍 (OUD) 的新疗法.
- 深度大脑刺激 (DBS) 是一种新兴的治疗精神疾病的干预措施,包括OUD,但面临着伦理辩论.
- 关于使用DBS治疗OUD的神经伦理影响的研究有限.
研究的目的:
- 分析公众对阿片类药物使用障碍 (OUD) 深度大脑刺激 (DBS) 的看法.
- 通过检查关于OUD的DBS新闻文章的在线评论来获得经验神经伦理的见解.
主要方法:
- 对来自"华盛顿邮报"两篇文章的292条网络评论进行了定性主题内容分析.
- 专注于确定关于OUD的DBS的公共话语中占主导地位的主题和转变.
主要成果:
- 关键主题包括对治疗结果的期望,将成归类为精神健康障碍以及资源分配问题.
- 在这两篇文章之间,人们观察到有争议的评论减少,对治疗需求的评论增加.
结论:
- 对于OUD的DBS的公众观点包括社会政治,技术和科学方面的考虑.
- 了解这些公众观点可以打击错误信息,并澄清OUD治疗中的DBS特定的伦理问题.
- 将OUD中的DBS与其他精神疾病的伦理问题进行比较至关重要.
关键词:
在 DBS 中,DBS 是 DBS 的代名词.吸毒成 吸毒成是一种成.评论 评论 分析 分析深度大脑刺激 刺激大脑心理健康 心理健康这是一种阿片类阿片类药物.类药物成 类药物成使用阿片类药物使用.精神疾病是一种精神疾病.耐药阿片类药物使用障碍滥用物质滥用物质滥用物质滥用物质滥用物质滥用物质滥用物质使用物质使用物质.这是一种治疗疗法.治疗治疗治疗治疗治疗治疗更多相关视频
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.2K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.8K
相关概念视频
Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
933
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
933
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Drug Therapy
450
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
450
